Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Soliton
Multi-site clinical study to evaluate the safety, efficacy and tolerability of Soliton's Rapid Acoustic Pulse (RAP) device fo the temporary improvement in the appearance of cellulite.
Age
18–50
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Female ages 18-50 years
Seeking treatment of cellulite in the thigh and/or buttock areas
Area of severe cellulite on the thigh and/or buttock with an average simplified Cellulite Severity Scale at Baseline ≥ 4.0 (Table 2)
Having at least one dimple, or ridge-depression, in the treatment area, with a depth of approximately 5 mm or greater.
Stable weight nominally +/- 5% for at least the past 6 months.
Body Mass Index (B.M.I.) is ≤ 30
Participant will not have had invasive or energy based cellulite treatments (liposuction, subcision, RF, laser, ESWT, etc.) for the prior 12 months.
Participant will not have used topical based cellulite treatments for prior 6 months and will not use during the trial.
Will not undergo any other cellulite treatments for a period of 12 months following RAP treatment.
Participant is willing to participate in study and adhere to follow-up schedule
Participant is able to read and comprehend English
Participant has completed the Informed Consent Form
You may not be if
Participant is unwilling to have research photos taken of treatment areas in the presence of Sponsor's researchers.
Participant is unwilling to have RAP treatment provided in the presence of Sponsor's researchers.
Participant is pregnant or planning to become pregnant during the duration of the study.
Has atrophic scars, or has a history of atrophic scars or keloids.
Tattoo or former tattoo at or near treatment area.
Metal or plastic implants in the area of the treatment (vascular stent, or implants in the hips, knees, etc.).
Active electronic implants such as pacemakers, defibrillators, cochlear implants, nerve/brain stimulators, drug pump, etc.
Medical disorder that would hinder the wound healing or immune response (no blood disorder, inflammatory disease, etc.).
History of coagulopathy(ies) and/or on anticoagulant medication.
Skin disorders (skin infections or rashes, extensive scarring, psoriasis, etc.) in the treatment area.
Current smoker.
Any surgical procedure in the prior 3 months, or planned during the duration of the study.
Clareo Health | Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite
